SCHEMBL2368909

SCHEMBL2368909

Cc1sc2nc(NCCO)nc(NCc3ccccn3)c2c1-c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 8/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PRKCI P41743 1/20 0.42
KCNH2 Q12809 6/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
CCNE1 P24864 2/20 0.38
CDK2 P24941 2/20 0.38
CDK5 Q00535 2/20 0.38
CTNNB1 P35222 1/20 0.38
TCF7L2 Q9NQB0 1/20 0.38
PDE10A Q9Y233 1/20 0.37
TNF P01375 1/20 0.37
MAPK1 P28482 1/20 0.37
NOD1 Q9Y239 1/20 0.37
KCNH3 Q9ULD8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2368953 0.93 KCNH2 (0.48) KCNA5MEN1KMT2APRKCIKCNH2
SCHEMBL2368734 0.88 PRKCI (0.39) KCNA5MEN1KMT2APRKCICDK2
SCHEMBL2369248 0.86 KCNA5 (0.45) KCNA5MEN1KMT2APRKCIKCNH2
SCHEMBL2368637 0.84 KCNA5 (0.43) KCNA5MEN1KMT2APRKCIKCNH2
SCHEMBL2368294 0.84 CLK4 (0.47) KCNA5MEN1KMT2AKCNH2SMN1; SMN2
SCHEMBL2368544 0.84 KCNA5 (0.44) KCNA5MEN1KMT2APRKCIKCNH2
SCHEMBL2375985 0.83 MEN1 (0.46) KCNA5MEN1KMT2AKCNH2CCNE1
SCHEMBL2368804 0.82 TNF (0.55) KCNA5KCNH2SMN1; SMN2CCNE1CDK2
SCHEMBL3382594 0.81 KCNH2 (0.49) KCNA5MEN1KMT2APRKCIKCNH2
SCHEMBL2368043 0.81 PRKCI (0.45) KCNA5PRKCIKCNH2SMN1; SMN2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022076-B2 Thieno[2,3-d]pyrimidine derivatives as potassium channel modulators; antiarrhythmia agents XENTION LIMITED (GB) 2011-09-20 US disclosed
EP-1641803-B3 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION LTD (GB) 2010-12-08 EP disclosed
EP-1641803-B1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION LTD (GB) 2009-03-18 EP disclosed
EP-1641803-A1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS Xention Discovery Limited (GB) 2006-04-05 EP disclosed
WO-2004111057-A1 THIENOPYRIMIDINE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS XENTION DISCOVERY LIMITED (GB) 2004-12-23 WO disclosed